GPT and steatosis: Patients with moderate-severe steatosis, compared to those without, had higher alanine aminotransferase (ALT) (28 vs. 23 U/L respectively, p < 0.001), and a higher rate of graft dysfunction, defined as serum ALT > 40 U/L (25.5% vs. 14.1%, p = 0.008; Supplementary Fig. 2).